Alzai Health Corp. ALZI.V
TSX
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -100.00% | -- | |||
| Cost of Revenue | 47.36% | -35.03% | |||
| Gross Profit | -105.78% | 53.48% | |||
| SG&A Expenses | -71.71% | 48.64% | |||
| Depreciation & Amortization | 12.50% | 23.08% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -55.61% | 68.19% | |||
| Operating Income | 54.80% | -65.17% | |||
| Income Before Tax | 50.36% | -60.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 50.36% | -60.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 50.36% | -60.12% | |||
| EBIT | 54.80% | -65.17% | |||
| EBITDA | 54.88% | -65.11% | |||
| EPS Basic | 50.49% | -55.73% | |||
| Normalized Basic EPS | 51.18% | -54.88% | |||
| EPS Diluted | 50.49% | -55.73% | |||
| Normalized Diluted EPS | 51.18% | -54.88% | |||
| Average Basic Shares Outstanding | 0.43% | 3.22% | |||
| Average Diluted Shares Outstanding | 0.43% | 3.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||